Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(38%)
Results Posted
100%(2 trials)

Phase Distribution

Ph not_applicable
3
38%
Ph phase_3
2
25%
Ph phase_2
1
13%
Ph phase_4
2
25%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(2)
Other(3)

Detailed Status

Recruiting3
unknown3
Completed2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (12.5%)
Phase 32 (25.0%)
Phase 42 (25.0%)
N/A3 (37.5%)

Trials by Status

completed225%
recruiting338%
unknown338%

Recent Activity

3 active trials
Showing 5 of 8
recruitingphase_4

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

NCT06468202
recruitingphase_3

Trial to Determine Effective Aspirin Dose in COPD

NCT05265299
recruitingphase_3

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

NCT06408181
completedphase_2

Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida

NCT03961360
unknownphase_4

162 mg of Aspirin for Prevention of Preeclampsia

NCT05221164
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06468202Phase 4

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

Recruiting
NCT05265299Phase 3

Trial to Determine Effective Aspirin Dose in COPD

Recruiting
NCT06408181Phase 3

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

Recruiting
NCT03961360Phase 2

Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida

Completed
NCT05221164Phase 4

162 mg of Aspirin for Prevention of Preeclampsia

Unknown
NCT03726177Not Applicable

Aspirin for Prevention of Preeclampsia

Unknown
NCT03725891Not Applicable

Aspirin for Prevention of Preeclampsia in Healthy, Nulliparous Obese and Overweight Pregnant Women

Unknown
NCT02189122Not Applicable

Comparative Effects of Aspirin and NHP-544C

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8